Estimation of D-dimer levels in COVID-19 patients and its correlation with age and gender

Kalash Chander

doi:10.18203/2349-3933.ijam20213201

Authors

Kalash Chander Department of Medicine, Sub-District Hospital, Kot-Bhalwal, Jammu, Jammu and Kashmir, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20213201

Keywords:

COVID-19, D-dimer, Thrombotic disorders, Women

Abstract

Background: COVID-19 patients show some kind of abnormal coagulation parameters, related to thrombotic disorders, which can act as marker of the disease. One such marker is D-dimer, which is a widely used fibrin degradation product test used for initial diagnosis of thrombotic disorders. D-dimer levels from patients coming in OPD of sub-district hospital Bishnah, Jammu were analyzed to estimate the degree of this relation to its severity, age and gender.

Methods: A retrospective study was conducted on the D-dimer data, collected from the patients coming in OPD of sub-district hospital Bishnah, Jammu, from March 2019 to March 2020. Randomly selected 134 patients infected with COVID-19, with known age and gender and confirmed by RT-PCR were included in the study.

Results: Out of these 134 patients, 76 were males (56.72%) and 58 were females (43.28%). 41.04% patients belonged to the age group 51 to 70 years; 92 patients had elevated levels of D-dimer levels, 52 (38.8%) patients showed D-dimer levels four-folds the safe level, >1000 ng/ml and a significant number of females (70.7%) were found to be with elevated D-dimer levels. Women were found to be at a higher risk of developing thrombotic disorders than men. There was slight relation of thrombotic disorders such as D-dimer with postmenopausal age of women as well.

Conclusions: This study has shown a clear guidance that women and older individuals are at a higher risk of developing thrombotic disorders during COVID-19 infection.

Metrics

Metrics Loading ...

References

World Health Organization. Coronavirus disease 019 C -19: situation report, 177.

Tang N, Bai H, Chen X, Gong J, Li D, Sun Z. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy. J Thromb Haemost. 2020;18(5):1094-9.

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7.

Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood. 2009;113(13):2878-87.

The Atlantic. Fact sheet: Why some people get sicker than others, 2020. Available at: https://www.theatlantic.com/health/archive/2020/04/coronavirus-immune-response/610228. Accessed on 8 July 2021.

Velavan TP, Meyer CG. Mild versus severe COVID-19: laboratory markers. Int J Infect Dis. 2020;25(4):304-7.

Pagana KD, Pagana TJ, Pagana TN. Mosby’s diagnostic and laboratory Test Reference. 14th ed. St. Louis: Elsevier; 2019.

Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thromb Haemo. 2020;9(4).

Kline JA, Williams GW, Hernandez-Nino J. D-dimer concentrations in normal pregnancy: new diagnostic thresholds are needed. Clinic Chem. 2005;51(5):825-9.